Milestone Pharmaceuticals Inc. (MIST)

Milestone Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	46.69	25.31	13.76	7.64	114.14	72.31
Short-Term Investments	35.9	44.38	52.24	56.95	-	70
Cash & Short-Term Investments	82.59	69.7	66	64.59	114.14	142.31
Cash Growth	8.07%	5.59%	2.20%	-43.42%	-19.79%	18.77%
Other Receivables	1.45	1.72	1.45	1.21	0.48	0.95
Receivables	1.45	1.72	1.45	1.21	0.48	0.95
Prepaid Expenses	2.58	1.84	3.18	6.01	4.3	5.43
Other Current Assets	0.06	0.67	2.4	-	-	-
Total Current Assets	86.67	73.93	73.03	71.8	118.92	148.69
Property, Plant & Equipment	1.08	1.57	2.19	2.68	0.93	1.29
Total Assets	87.75	75.5	75.23	74.48	119.85	149.97
Accounts Payable	3.18	1.93	3.98	2.26	4.38	4.64
Accrued Expenses	6.86	5.62	2.7	3.38	2.17	1.27
Current Portion of Leases	0.48	0.57	0.55	0.5	0.22	0.25
Total Current Liabilities	10.52	8.13	7.23	6.14	6.78	6.16
Long-Term Debt	56.21	53.35	49.77	-	-	-
Long-Term Leases	0.52	0.87	1.46	2	0.47	0.7
Total Liabilities	67.25	62.35	58.46	8.14	7.25	6.86
Common Stock	311.78	288.05	260.5	273.9	251.9	251.68
Additional Paid-In Capital	66.27	39.57	33.83	24.44	15.71	8.53
Retained Earnings	-413.19	-367.55	-326.03	-266.34	-207.95	-163.47
Comprehensive Income & Other	55.65	53.08	48.46	34.35	52.94	46.37
Total Common Equity	20.5	13.15	16.77	66.35	112.6	143.12
Shareholders' Equity	20.5	13.15	16.77	66.35	112.6	143.12
Total Liabilities & Equity	87.75	75.5	75.23	74.48	119.85	149.97
Total Debt	57.21	54.8	51.78	2.49	0.7	0.94
Net Cash (Debt)	25.38	14.9	14.23	62.09	113.44	141.37
Net Cash Growth	13.29%	4.71%	-77.09%	-45.26%	-19.75%	18.50%
Net Cash Per Share	0.34	0.24	0.33	1.46	2.71	4.82
Filing Date Shares Outstanding	101.58	66.26	43.06	42.8	42.23	41.25
Total Common Shares Outstanding	101.58	66.26	43.06	42.8	42.23	41.25
Working Capital	76.15	65.8	65.81	65.66	112.15	142.53
Book Value Per Share	0.20	0.20	0.39	1.55	2.67	3.47
Tangible Book Value	20.5	13.15	16.77	66.35	112.6	143.12
Tangible Book Value Per Share	0.20	0.20	0.39	1.55	2.67	3.47
Machinery	-	0.4	0.38	0.28	0.43	0.43
Leasehold Improvements	-	0.09	0.09	0.1	0.03	0.03

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q